<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">iarjbm</journal-id><journal-id journal-id-type="pubmed">IARJBM</journal-id><journal-id journal-id-type="publisher">IARJBM</journal-id><issn>2708-5147</issn></journal-meta><article-meta><article-id pub-id-type="doi">https://doi.org/10.47310/iarjbm.2026.v07i02.001</article-id><title-group><article-title>Digital Transformation and AI-Driven Supply Chain Management in the Pharmaceutical Sector: Opportunities and Challenges</article-title></title-group><abstract>The&amp;nbsp;pharmaceutical&amp;nbsp;supply&amp;nbsp;chain&amp;nbsp;is&amp;nbsp;a&amp;nbsp;critical&amp;nbsp;component&amp;nbsp;of&amp;nbsp;the global healthcare system, ensuring the efficient delivery of life-saving drugs to patients. However, challenges such as inventory management, counterfeit drugs, demand forecasting, and regulatory compliance necessitate innovative solutions. Artificial Intelligence (AI) has emerged as a transformative tool in optimizing pharmaceutical supply chain operations. This review systematically examines the applications, benefits,&amp;nbsp;challenges,&amp;nbsp;and&amp;nbsp;future&amp;nbsp;prospects&amp;nbsp;of&amp;nbsp;AI&amp;nbsp;in&amp;nbsp;pharmaceutical&amp;nbsp;supply chain&amp;nbsp;management.&amp;nbsp;By&amp;nbsp;analyzing&amp;nbsp;current&amp;nbsp;literature,&amp;nbsp;this&amp;nbsp;article&amp;nbsp;highlights AI-driven solutions such as predictive analytics, blockchain integration, and machine learning algorithms, offering a comprehensive understanding of their impact on efficiency, accuracy, and transparency in&amp;nbsp;the pharmaceutical&amp;nbsp;supply&amp;nbsp;chain.&amp;nbsp;Furthermore,&amp;nbsp;the&amp;nbsp;study&amp;nbsp;explores&amp;nbsp;the strategic&amp;nbsp;implications&amp;nbsp;of&amp;nbsp;AI&amp;nbsp;adoption&amp;nbsp;in&amp;nbsp;emerging&amp;nbsp;markets,&amp;nbsp;with&amp;nbsp;a&amp;nbsp;specific focus on the Turkish pharmaceutical sector, addressing unique regional barriers and opportunities for digital transformation.</abstract></article-meta></front><body /><back /></article>